Do DOACs improve safety and efficacy outcomes compared to VKAs in patients with left ventricular thrombus?
In a global retrospective study, DOACs appeared to offer superior safety and efficacy compared to VKAs for the treatment of left ventricular thrombus.
DOACs demonstrated better safety and efficacy outcomes when compared with VKAs in left ventricular thrombus treatment, with or without recent acute coronary syndrome.
Yao et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: